The Department of Defense is seeking quotes for specific pharmaceutical agents to be considered for its Uniform Formulary. The Pharmacy and Therapeutics Committee will review six newly approved drugs, including Jascayd and Vyscoxa, in a meeting scheduled for February 2026. The agency may award blanket purchase and discount program agreements based on the formulary decisions. A mandatory pre-quotation teleconference is scheduled for November 20, 2025. Clinical question responses must be submitted by a deadline specified within the solicitation documents.